Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Successful management of obstructive jaundice due to gallstones with eculizumab in a patient with paroxysmal nocturnal hemoglobinuria.

Kawano H, Minagawa K, Wakahashi K, Kawano Y, Sada A, Matsui T, Hirano H, Shiomi H, Ku Y, Katayama Y.

Intern Med. 2012;51(18):2613-6. Epub 2012 Sep 15.

2.

Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS clinical trial.

Kanakura Y, Ohyashiki K, Shichishima T, Okamoto S, Ando K, Ninomiya H, Kawaguchi T, Nakao S, Nakakuma H, Nishimura J, Kinoshita T, Bedrosian CL, Valentine ME, Khursigara G, Ozawa K, Omine M.

Int J Hematol. 2011 Jan;93(1):36-46. doi: 10.1007/s12185-010-0748-9. Epub 2011 Jan 12.

PMID:
21222185
3.

[Successful management of orthopedic operations requiring general anesthesia in a PNH patient after introduction of eculizumab].

Tsutsui M, Gotoh A, Yasuda H, Ono E, Tanaka M, Komatsu N.

Rinsho Ketsueki. 2015 Apr;56(4):423-7. doi: 10.11406/rinketsu.56.423. Japanese.

PMID:
25971274
4.

[Successful eculizumab treatment for multiple coronary thrombosis complicated in paroxysmal nocturnal hemoglobinuria].

Taniguchi A, Ikezoe T, Takeuchi A, Togitani K, Yoshimoto M, Tanioka K, Kitaoka H, Yokoyama A.

Rinsho Ketsueki. 2014 Aug;55(8):965-9. Japanese.

PMID:
25186487
5.

Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.

Hillmen P, Hall C, Marsh JC, Elebute M, Bombara MP, Petro BE, Cullen MJ, Richards SJ, Rollins SA, Mojcik CF, Rother RP.

N Engl J Med. 2004 Feb 5;350(6):552-9.

6.

Eculizumab: A novel therapy for paroxysmal nocturnal hemoglobinuria.

Zareba KM.

Drugs Today (Barc). 2007 Aug;43(8):539-46. Review.

PMID:
17925885
7.

Eculizumab: a guide to its use in paroxysmal nocturnal hemoglobinuria.

Keating GM, Lyseng-Williamson KA, McKeage K.

BioDrugs. 2012 Apr 1;26(2):125-30. doi: 10.2165/11208420-000000000-00000.

PMID:
22350448
8.

Successful use of eculizumab in a pediatric patient treated for paroxysmal nocturnal hemoglobinuria.

Bauters T, Bordon V, Robays H, Benoit Y, Dhooge C.

J Pediatr Hematol Oncol. 2012 Nov;34(8):e346-8. doi: 10.1097/MPH.0b013e318258079a.

PMID:
22767128
9.

Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria.

Schrezenmeier H, Höchsmann B.

Expert Rev Hematol. 2009 Feb;2(1):7-16. doi: 10.1586/17474086.2.1.7. Review.

PMID:
21082989
10.

Perisurgical induction of eculizumab in a patient with paroxysmal nocturnal hemoglobinuria: its inhibition of surgery-triggered hemolysis and the consequence of subsequent discontinuation.

Kurita N, Obara N, Fukuda K, Nishikii H, Sato S, Inagawa S, Kurokawa T, Owada Y, Ninomiya H, Chiba S.

Blood Coagul Fibrinolysis. 2013 Sep;24(6):658-62. doi: 10.1097/MBC.0b013e328360d057.

PMID:
23917586
11.

A patient with paroxysmal nocturnal hemoglobinuria being treated with eculizumab who underwent laparoscopic cholecystectomy: report of a case.

Moriyama M, Nagata T, Yoshioka I, Hashimoto I, Matsui K, Okumura T, Tsukada K.

Surg Case Rep. 2015;1(1):57. doi: 10.1186/s40792-015-0059-8. Epub 2015 Jul 11.

12.

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.

Hillmen P, Young NS, Schubert J, Brodsky RA, Socié G, Muus P, Röth A, Szer J, Elebute MO, Nakamura R, Browne P, Risitano AM, Hill A, Schrezenmeier H, Fu CL, Maciejewski J, Rollins SA, Mojcik CF, Rother RP, Luzzatto L.

N Engl J Med. 2006 Sep 21;355(12):1233-43.

13.

Managing a pregnant patient with paroxysmal nocturnal hemoglobinuria in the era of eculizumab.

Danilov AV, Brodsky RA, Craigo S, Smith H, Miller KB.

Leuk Res. 2010 May;34(5):566-71. doi: 10.1016/j.leukres.2009.10.025. Epub 2009 Dec 1. Review.

PMID:
19954846
14.

Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival.

Kelly RJ, Hill A, Arnold LM, Brooksbank GL, Richards SJ, Cullen M, Mitchell LD, Cohen DR, Gregory WM, Hillmen P.

Blood. 2011 Jun 23;117(25):6786-92. doi: 10.1182/blood-2011-02-333997. Epub 2011 Apr 1.

15.
16.
17.
18.

Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab.

Singer AL, Locke JE, Stewart ZA, Lonze BE, Hamilton JP, Scudiere JR, Anders RA, Rother RP, Brodsky RA, Cameron AM.

Liver Transpl. 2009 May;15(5):540-3. doi: 10.1002/lt.21714.

19.
20.

Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial.

Kanakura Y, Ohyashiki K, Shichishima T, Okamoto S, Ando K, Ninomiya H, Kawaguchi T, Nakao S, Nakakuma H, Nishimura J, Kinoshita T, Bedrosian CL, Ozawa K, Omine M.

Int J Hematol. 2013 Oct;98(4):406-16. doi: 10.1007/s12185-013-1404-y. Epub 2013 Aug 11.

PMID:
23934275
Items per page

Supplemental Content

Write to the Help Desk